Detalhe da pesquisa
1.
A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen allo-immunized patients.
Br J Haematol
; 189(3): 551-558, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32086819